Cleared Traditional

K891461 - SURGILASE YAG 100 SURGICAL ND:YAG LASER...

K891461 is the FDA 510(k) clearance for SURGILASE YAG 100 SURGICAL ND:YAG LASER... by Surgilase, Inc.. It is a Class 2 General & Plastic Surgery device (product code GEX) cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K891461 · Surgilase, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1989
Decision
22d
Days
Class 2
Risk

K891461 is an FDA 510(k) clearance for the SURGILASE YAG 100 SURGICAL ND:YAG LASER/GEN SURG. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Surgilase, Inc. (Warwick, US). The FDA issued a Cleared decision on April 6, 1989 after a review of 22 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Surgilase, Inc. devices

Submission Details

510(k) Number K891461 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 15, 1989
Decision Date April 06, 1989
Days to Decision 22 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
93d faster than avg
Panel avg: 115d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 737
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K891461.
SHARPLAN SERIES 2900 SYNTHETIC CONTACT TIPS
K894211 · Sharplan Lasers, Inc. · Aug 1989
SHARPLAN 1075 CO2 LASER
K893206 · Sharplan Lasers, Inc. · Jun 1989
SHARPLAN MODEL 1050 SEALED-OFF CO2 SURGICAL LASER
K890287 · Sharplan Lasers, Inc. · Apr 1989
SHARPLAN MODEL 750 REMOTE CONTROL UNIT (RCU)
K890286 · Sharplan Lasers, Inc. · Apr 1989
MODIFIED LABELING PACKAGING SHARPLAN 2100 STERILE
K891088 · Sharplan Lasers, Inc. · Mar 1989
SHARPLAN MODEL 2106
K891016 · Sharplan Lasers, Inc. · Mar 1989